206 related articles for article (PubMed ID: 31174295)
1. A Practical Perspective: The Effect of Ligand Conformers on the Negative Image-Based Screening.
Ahinko M; Kurkinen ST; Niinivehmas SP; Pentikäinen OT; Postila PA
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31174295
[TBL] [Abstract][Full Text] [Related]
2. Negative Image-Based Rescoring: Using Cavity Information to Improve Docking Screening.
Pentikäinen OT; Postila PA
Methods Mol Biol; 2021; 2266():141-154. PubMed ID: 33759125
[TBL] [Abstract][Full Text] [Related]
3. Negative Image-Based Screening: Rigid Docking Using Cavity Information.
Postila PA; Kurkinen ST; Pentikäinen OT
Methods Mol Biol; 2021; 2266():125-140. PubMed ID: 33759124
[TBL] [Abstract][Full Text] [Related]
4. Ligand-Enhanced Negative Images Optimized for Docking Rescoring.
Kurkinen ST; Lehtonen JV; Pentikäinen OT; Postila PA
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887220
[TBL] [Abstract][Full Text] [Related]
5. Improving Docking Performance Using Negative Image-Based Rescoring.
Kurkinen ST; Niinivehmas S; Ahinko M; Lätti S; Pentikäinen OT; Postila PA
Front Pharmacol; 2018; 9():260. PubMed ID: 29632488
[TBL] [Abstract][Full Text] [Related]
6. Getting Docking into Shape Using Negative Image-Based Rescoring.
Kurkinen ST; Lätti S; Pentikäinen OT; Postila PA
J Chem Inf Model; 2019 Aug; 59(8):3584-3599. PubMed ID: 31290660
[TBL] [Abstract][Full Text] [Related]
7. Optimization of Cavity-Based Negative Images to Boost Docking Enrichment in Virtual Screening.
Kurkinen ST; Lehtonen JV; Pentikäinen OT; Postila PA
J Chem Inf Model; 2022 Feb; 62(4):1100-1112. PubMed ID: 35133138
[TBL] [Abstract][Full Text] [Related]
8. Fragment- and negative image-based screening of phosphodiesterase 10A inhibitors.
Jokinen EM; Postila PA; Ahinko M; Niinivehmas S; Pentikäinen OT
Chem Biol Drug Des; 2019 Oct; 94(4):1799-1812. PubMed ID: 31260165
[TBL] [Abstract][Full Text] [Related]
9. Virtual Screening Strategy to Identify Retinoic Acid-Related Orphan Receptor γt Modulators.
Jokinen EM; Niemeläinen M; Kurkinen ST; Lehtonen JV; Lätti S; Postila PA; Pentikäinen OT; Niinivehmas SP
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110655
[TBL] [Abstract][Full Text] [Related]
10. Matrix-based Molecular Descriptors for Prospective Virtual Compound Screening.
Grisoni F; Reker D; Schneider P; Friedrich L; Consonni V; Todeschini R; Koeberle A; Werz O; Schneider G
Mol Inform; 2017 Jan; 36(1-2):. PubMed ID: 27650559
[TBL] [Abstract][Full Text] [Related]
11. Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation.
Razzaghi-Asl N; Mirzayi S; Mahnam K; Sepehri S
J Mol Graph Model; 2018 Aug; 83():138-152. PubMed ID: 29936228
[TBL] [Abstract][Full Text] [Related]
12. Molecular Docking of Bioactive Compounds Against BRCA and COX Proteins.
Prog Drug Res; 2016; 71():181-3. PubMed ID: 26939289
[TBL] [Abstract][Full Text] [Related]
13. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
Zhang X; Wong SE; Lightstone FC
J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a potent cyclooxygenase-2 inhibitor, S4, through docking-based pharmacophore screening, in vivo and in vitro estimations.
Tseng TS; Chuang SM; Hsiao NW; Chen YW; Lee YC; Lin CC; Huang C; Tsai KC
Mol Biosyst; 2016 Jul; 12(8):2541-51. PubMed ID: 27265567
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive assessment of flexible-ligand docking algorithms: current effectiveness and challenges.
Huang SY
Brief Bioinform; 2018 Sep; 19(5):982-994. PubMed ID: 28334282
[TBL] [Abstract][Full Text] [Related]
16. Comparison of virtual high-throughput screening methods for the identification of phosphodiesterase-5 inhibitors.
Niinivehmas SP; Virtanen SI; Lehtonen JV; Postila PA; Pentikäinen OT
J Chem Inf Model; 2011 Jun; 51(6):1353-63. PubMed ID: 21591817
[TBL] [Abstract][Full Text] [Related]
17. Structural Probing, Screening and Structure-Based Drug Repositioning Insights into the Identification of Potential Cox-2 Inhibitors from Selective Coxibs.
Bommu UD; Konidala KK; Pamanji R; Yeguvapalli S
Interdiscip Sci; 2019 Jun; 11(2):153-169. PubMed ID: 29236213
[TBL] [Abstract][Full Text] [Related]
18. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.
Morency LP; Gaudreault F; Najmanovich R
Methods Mol Biol; 2018; 1762():367-388. PubMed ID: 29594781
[TBL] [Abstract][Full Text] [Related]
19. Molecular docking, molecular modeling, and molecular dynamics studies of azaisoflavone as dual COX-2 inhibitors and TP receptor antagonists.
Hadianawala M; Mahapatra AD; Yadav JK; Datta B
J Mol Model; 2018 Feb; 24(3):69. PubMed ID: 29480373
[TBL] [Abstract][Full Text] [Related]
20. Studies of the benzopyran class of selective COX-2 inhibitors using 3D-QSAR and molecular docking.
Yadav DK; Saloni ; Sharma P; Misra S; Singh H; Mancera RL; Kim K; Jang C; Kim MH; Pérez-Sánchez H; Choi EH; Kumar S
Arch Pharm Res; 2018 Dec; 41(12):1178-1189. PubMed ID: 28822076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
